Loading…
Loading…
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial
Freedberg, Daniel E., Toussaint, Nora C., Chen, Sway P., Ratner, Adam J., Whittier, Susan, Wang, Timothy C., Wang, Harris H., Abrams, Julian A.
Published in Gastroenterology (New York, N.Y. 1943) (01.10.2015)
Published in Gastroenterology (New York, N.Y. 1943) (01.10.2015)
Get full text
Journal Article
Loading…
Loading…
Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies
Angiolillo, D J, Gibson, C M, Cheng, S, Ollier, C, Nicolas, O, Bergougnan, L, Perrin, L, LaCreta, F P, Hurbin, F, Dubar, M
Published in Clinical pharmacology and therapeutics (01.01.2011)
Published in Clinical pharmacology and therapeutics (01.01.2011)
Get more information
Journal Article
Loading…
H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota
Martín-Núñez, Gracia Mª, Cornejo-Pareja, Isabel, Coin-Aragüez, Leticia, Roca-Rodríguez, Mª del Mar, Muñoz-Garach, Araceli, Clemente-Postigo, Mercedes, Cardona, Fernando, Moreno-Indias, Isabel, Tinahones, Francisco J.
Published in PloS one (14.03.2019)
Published in PloS one (14.03.2019)
Get full text
Journal Article
Loading…
A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers
Frelinger, Andrew L., Lee, Ronald D., Mulford, Darcy J., Wu, Jingtao, Nudurupati, Sai, Nigam, Anu, Brooks, Julie K., Bhatt, Deepak L., Michelson, Alan D.
Published in Journal of the American College of Cardiology (03.04.2012)
Published in Journal of the American College of Cardiology (03.04.2012)
Get full text
Journal Article
Loading…
Effect of tildrakizumab (MK‐3222), a high affinity, selective anti‐IL23p19 monoclonal antibody, on cytochrome P450 metabolism in subjects with moderate to severe psoriasis
Khalilieh, Sauzanne, Hussain, Azher, Montgomery, Diana, Levine, Vanessa, Shaw, Peter M., Bodrug, Inga, Mekokishvili, Lally, Bailey‐Smith, Candice, Glasgow, Xiaoli S., Cheng, Amy, Martinho, Monika, Iwamoto, Marian
Published in British journal of clinical pharmacology (01.10.2018)
Published in British journal of clinical pharmacology (01.10.2018)
Get full text
Journal Article
Loading…
Geneva Cocktail for Cytochrome P450 and P‐Glycoprotein Activity Assessment Using Dried Blood Spots
Bosilkovska, M, Samer, C F, Déglon, J, Rebsamen, M, Staub, C, Dayer, P, Walder, B, Desmeules, J A, Daali, Y
Published in Clinical pharmacology and therapeutics (01.09.2014)
Published in Clinical pharmacology and therapeutics (01.09.2014)
Get full text
Journal Article
Loading…
Loading…
Loading…
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling
Yang, Ruwei, Lin, Yaqi, Chen, Kaifeng, Huang, Jie, Yang, Shuang, Yao, An, Yang, Xiaoyan, Lei, Deqing, Xiao, Jing, Yang, Guoping, Pei, Qi
Published in The AAPS journal (12.07.2024)
Published in The AAPS journal (12.07.2024)
Get full text
Journal Article
Loading…
Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study
Derungs, Adrian, Donzelli, Massimiliano, Berger, Benjamin, Noppen, Christoph, Krähenbühl, Stephan, Haschke, Manuel
Published in Clinical pharmacokinetics (01.01.2016)
Published in Clinical pharmacokinetics (01.01.2016)
Get full text
Journal Article
Loading…
Use of a combination formulation of bismuth, metronidazole and tetracycline with omeprazole as a rescue therapy for eradication of Helicobacter pylori
Delchier, J. C., Malfertheiner, P., Thieroff‐Ekerdt, R.
Published in Alimentary pharmacology & therapeutics (01.07.2014)
Published in Alimentary pharmacology & therapeutics (01.07.2014)
Get full text
Journal Article
Loading…
Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease
Carroll, Thomas L, Werner, Astrid, Nahikian, Kael, Dezube, Aaron, Roth, Douglas F
Published in The Laryngoscope (01.10.2017)
Published in The Laryngoscope (01.10.2017)
Get more information
Journal Article
Loading…
Loading…
Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database
Adachi, Koichiro, Ohyama, Katsuhiro, Tanaka, Yoichi, Murayama, Norie, Shimizu, Makiko, Saito, Yoshiro, Yamazaki, Hiroshi
Published in Biological & pharmaceutical bulletin (2024)
Published in Biological & pharmaceutical bulletin (2024)
Get full text
Journal Article
Loading…
Loading…
Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric Lesions
You, Wei-cheng, Brown, Linda M., Zhang, Lian, Li, Ji-you, Jin, Mao-lin, Chang, Yun-shen, Ma, Jun-ling, Pan, Kai-feng, Liu, Wei-dong, Hu, Yuanreng, Crystal-Mansour, Susan, Pee, David, Blot, William J., Fraumeni, Joseph F., Xu, Guang-wei, Gail, Mitchell H.
Published in JNCI : Journal of the National Cancer Institute (19.07.2006)
Published in JNCI : Journal of the National Cancer Institute (19.07.2006)
Get full text
Journal Article
Loading…
Small bowel mucosal injury is reduced in healthy subjects treated with celecoxib compared with ibuprofen plus omeprazole, as assessed by video capsule endoscopy
GOLDSTEIN, J. L., EISEN, G. M., LEWIS, B., GRALNEK, I. M., AISENBERG, J., BHADRA, P., BERGER, M. F.
Published in Alimentary pharmacology & therapeutics (15.05.2007)
Published in Alimentary pharmacology & therapeutics (15.05.2007)
Get full text
Journal Article
Loading…
PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: Results of two 6-month, phase 3 studies
Whellan, David J., Goldstein, Jay L., Cryer, Byron L., Eisen, Glenn M., Lanas, Angel, Miller, Alan B., Scheiman, James M., Fort, John G., Zhang, Ying, O’Connor, Christopher
Published in The American heart journal (01.10.2014)
Published in The American heart journal (01.10.2014)
Get full text
Journal Article